Welcome to Vertex
Clinical Trials

Vertex Pharmaceuticals is focused on discovering medicines for people with serious diseases.

Developing innovative medicines requires carefully designed studies in humans that evaluate the safety and efficacy of an investigational medicine. 

Featured Trials

Phase 1
Cystic Fibrosis
Eligibility Criteria
18 Years-65 Years
Trial Description
A Phase 1 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Location
22 location(s)
Phase 1
Diabetes Type 1
Eligibility Criteria
18 Years-65 Years
Trial Description
A Safety, Tolerability and Efficacy Study of VX-880 in Participants with Type 1 Diabetes
Location
9 location(s)
Phase 2, Phase 3
Kidney Disease
Eligibility Criteria
10 Years-65 Years
Trial Description
Phase 2/3 Adaptive Study of VX-147 in Adultand Pediatric Participants with APOL1-Mediated Proteinuric Kidney Disease
Location
164 location(s)

Learn About the Vertex Registry

Join and get connected to clinical trials that may be right for you

When you volunteer to participate in clinical research, you help advance medical care for yourself and your community. We make it easy to get involved in the research that matters to you.

Our commitment to clinical trial diversity

Clinical trials should be representative of all people living with a specific disease. Ensuring appropriate diversity in participant characteristics helps Vertex to develop and deliver innovative medicines that can make a meaningful difference in the lives of all people living with that disease.

Vertex recognizes that individuals may respond differently to a given treatment based on their age, biological sex, weight, race, ethnicity, geography and other factors. By providing equitable access to and including people from diverse backgrounds and locations, clinical trials can show if the potential treatments are safe and effective across patient populations.

Vertex's aim is to sponsor inclusive clinical trials that represent the diversity of people living with the disease.

Our commitment to transparency

Vertex is committed to advancing medicine and improving patients' lives.
This includes the responsible sharing of clinical trial data with qualified researchers. 

A scientific board reviews all proposals for the use of data. Proposals are reviewed for the nature of the request, the merit of the research proposed, and the intended use of the data. Approvals are at the discretion of Vertex.

If you are a qualified researcher interested in submitting a request for Vertex clinical trial data, please submit your proposal here.